Analyzing the utility of blood coagulation test to diagnose blood clot lysis
Not Applicable
- Conditions
- Health Condition 1: D689- Coagulation defect, unspecified
- Registration Number
- CTRI/2021/08/035510
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All TEG request for Citrated Kaolin TEG test
Exclusion Criteria
Patients diagnosed with sepsis (ongoing project, so to avoid data duplication), age less than 18 years, Death within 48 hours, Patients who were discharged against medical advice, patients with a history of ongoing thrombolysis therapy, patients on anti fibrinolytic drugs and other modalities of TEG.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method categorizing the diagnosed fibrinolytic activity into primary and secondary based on TEG algorithm. Sensitivity and Area under the curve for Thrombin generation assay in diagnosing fibrinolysis activity compared to thromboelastogram. Correlation between TEG and TGA paramters as per manufacturer algorithm.Timepoint: Primary outcome - 24 months
- Secondary Outcome Measures
Name Time Method clinical correlation with the diagnosis of primary and secondary fibrinolysis. Correlation of laboratory tests and TEG parameters. Management given to the patient and clinical outcome of patientsTimepoint: 24 months